About 200 reports

  • 5.3 GLOBAL AND HISTORICAL TRENDS
  • 5.1 DISEASE BACKGROUND

The most common comorbidities associated with OUD are psychiatric disorders such as major depression, anxiety, and personality disorders.

  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Forecast
  • Products and services segmentation (2019)
  • Products and services segmentation (2019)

While there is not one factor that is known to cause these disorders, there are numerous measurable factors that can contribute to the development of these diseases. disorders.

  • Addiction Disorder
  • Mental Health
  • Pathology
  • Canada
  • Demand
  • Clinical Trial profile. 168 Trial Title
  • 5. All the trials included are unique trials.

## ## ## ## ## ## ## ## China ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are ta

  • Antipsychotic
  • Cardiovascular Drug
  • Clinical Trial
  • Neurology
  • Psychotic Disorder
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SANDOZ

Therapy Area Cardiovascular Central Nervous System Dermatology Ear Nose Throat Disorders Gastrointestinal Genetic Disorders Genito Urinary System And Sex Hormones Hormonal Disorders Infectious Disease Musculoskeletal Oncology Respiratory Women' s Health Immunology No. of Deals

  • Biosimilar
  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Sandoz Inc.
  • Description

Chapter ## provides an introduction to the report.

  • Mental Health
  • Pathology
  • World
  • Demand
  • GLOBAL PREMATURE EJACULATION TREATMENT MARKET BY SSRIS 2016-2021 ($ MILLIONS)
  • SSRIS

These drugs find applications in the treatment of anxiety, depression, and personality disorders.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Eli Lilly & Co.
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Dermatological Condition
  • Healthcare
  • Pathology
  • Pharmaceutical
  • LEO Pharma A/S
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SANDOZ
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SBI BIOTECH

Article ##.

  • Healthcare
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY HOVERINK BIOTECHNOLOGIES INC, H1 2019
  • HOVERINK BIOTECHNOLOGIES INC

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Chemotherapy
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • Helsinn Group
  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbid Conditions Associated with OUD

The most common comorbidities associated with OUD are psychiatric disorders such as major depression, anxiety, and personality disorders.

  • Epidemiology
  • Hospital
  • Opioid
  • United States
  • Forecast
  • Clinical Trial profile. 35 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Clinical Trial
  • Mental Health
  • Psychotic Disorder
  • Therapy
  • Pfizer Inc.
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H1 2018
  • PIPELINE BY COTINGA PHARMACEUTICALS INC, H1 2018

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Hospital
  • Oncology
  • Therapy
  • World
  • AstraZeneca PLC
  • ASSET PURCHASE

Rx PedPRM is to treat sleep disorders in children with autism spectrum disorders (ASD) and neurogenetic diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • M&A
  • Aspen Pharmacare Holdings Limited
  • Pipeline by FLX Bio Inc, H1 2018
  • FLX Bio Inc

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Protein Therapy
  • Therapy
  • United States
  • World
  • Kyowa Hakko Kirin Co., Ltd.
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2018
  • JOHNSON & JOHNSON

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Product Initiative
  • Apexigen, Inc.
  • ACTIVIOMICS ENTERS INTO RESEARCH AGREEMENT WITH KYOWA HAKKO
  • ACTIVIOMICS EXTENDS RESEARCH AGREEMENT WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Influenza
  • Pharmaceutical
  • United Kingdom
  • hVIVO plc
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • PIPELINE BY TAKEDA PHARMACEUTICAL CO LTD, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Digestive System Disorder
  • Therapy
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • UNIPOLAR DEPRESSION

The others include disorders such as obsessive-compulsive disorder, post-traumatic stress disorder, personality disorder, Tourette syndrome, and autism.

  • Antipsychotic
  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • SANFORD HEALTH ACQUIRES HEMATECH, DRUG DEVELOPMENT COMPANY

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Health Services
  • Healthcare
  • Pharmaceutical
  • United States
  • Caladrius Biosciences, Inc.
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • PIPELINE BY HORIZON DISCOVERY GROUP PLC, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Hospital
  • Oncology
  • Research And Development
  • Therapy
  • AstraZeneca PLC
  • FUJIFILM FORMS JOINT VENTURE WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • FUJIFILM Holdings Corporation
  • ORPEA SA: KEY FACTS
  • LEADING COMPANIES

Orpea' s psychiatric clinic facilities provide services for patients with acute mental pathologies, such as mood disorders, anxiety disorders, addiction, overuse or burnout syndromes, chronic fatigue syndrome, fibromyalgia, sleep disorders, eating disorders, b

  • Health Care Provider
  • Health Services
  • Healthcare
  • Western Europe
  • Market Size
  • 11.2 ABBREVIATIONS
  • RISK FACTORS AND COMORBIDITIES FOR BED

DBT can be appropriate for patients suffering from borderline personality disorder (BPD), depression, bipolar disorder, and post-traumatic stress disorder (PTSD).

  • Eating Disorder
  • Mental Health
  • Pathology
  • Therapy
  • United States
  • KYOWA HAKKO KIRIN CO LTD
  • PIPELINE BY MEDIMMUNE LLC, H2 2018

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • United States
  • MedImmune, LLC
  • 4.5 Personality Disorders
  • 20 Personality disorders market, 2014 - 2025 (USD Billion)

Furthermore, increasing incidence of depression and substance abuse cases services provided by various hospitals for behavioral disorders is anticipated to boost the market growth.

  • Healthcare
  • Mental Health
  • United States
  • Forecast
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Japan
  • FUJIFILM Holdings Corporation
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Adimab LLC
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Biotechnology
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Genmab group
  • Kyowa Hakko Kirin Enters into Licensing Agreement with Ardelyx

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Ardelyx, Inc.
  • Pipeline by Kyowa Hakko Kirin Co Ltd, H2 2018
  • C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Companies Involved in Therapeutics Development

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Lymphoma
  • Therapy
  • United States
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd.